Venetoclax With 5-Azacytidine Effective in Treating Patients With Multiple Myeloma : vimarsana.com

Venetoclax, which is approved for leukemia, blocks a function of the BCL-2 protein and has previously shown efficacy in a small proportion of patients with multiple myeloma.

Related Keywords

, Department Of Physiology , Cancer Centre , Department Of Pathology , Medical Physics ,